Stock Ratings / Health Care / CNTN / insiders

PDSB (45) PEPG (38) VRXA (60) CUE (33) ⌘ Pro Terminal →

Canton Strategic Holdings Inc. (CNTN) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

$1.95 -4.88% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $1.93

Canton Strategic Holdings Inc. (CNTN) carries a Roarable Rating of D- (Sell) with 37/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (37/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE D- • RED ALERT Cap $163.3M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on CNTN Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is CNTN stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-02, Canton Strategic Holdings Inc. (NASDAQ: CNTN) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 37/100 at a spot price of $1.95 (-4.88% 1D, market cap $163.3M). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 8/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, CNTN ranks #613 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does CNTN compare to PDSB and PEPG in the Health Care sector?

▼

Within the Health Care sector (Biotechnology: Pharmaceutical Preparations), CNTN carries a Roarable D- (37/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -4.1%. By comparison, PDSB (PDS Biotechnology Corporation) holds a D grade (45/100 RQD, P/E N/A, ROIC -35.0%, cap $162.8M) and PEPG (PepGen Inc.) posts a D- grade (38/100 RQD, P/E N/A, ROIC -35.0%, cap $166.9M). Among the 5-stock peer group, CNTN leads on earnings multiple (N/A) while CNTN leads on capital efficiency (-4.1% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for CNTN?

▼

Per CNTN's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001861657), Canton Strategic Holdings Inc. generated $0 in revenue, -$35.9M in net income, and -$16.1M in free cash flow against $519.1M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $1.93 (-1.07%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 8/20 (D-) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (37/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-8.1% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • D-

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D

Each axis scored 0–20

12M PRICE TARGET CONE-9.2% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for CNTN)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (37/100 Composite)

🔍 WHY CNTN SCORES 37/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+10/20 pts (27% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 2/9

▲ #2 Bullish Driver: Cash Engine Quality+8/20 pts (22% of score)

SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 52% Gross Margin

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade D$2.11-19.4% Next Q

Q2 (-2Q)

Grade D$1.70+9.4% Next Q

Q3 (-1Q)

Grade D$1.86+4.8% Next Q

Current

Grade D-$1.95-8.1% Hist 90D α

Trajectory: D (45) → D- (37)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a CNTN Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While CNTN currently carries a cautious 37/100 (D-) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($2.15) and Max Pain ($2.05) forces dealer call-delta covering toward $7.23.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $CNTN• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “CNTN Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 37%NO 63%Trade / Inspect Odds →

SEC FORM 4 × 13F HEDGE FUNDS × CONGRESSIONAL STOCK ACT

CNTN Smart-Money Thermometer: NET EXECUTIVE TRIMMING / PROFIT-TAKING

Explore All 13F & Congress Whales →

▲ Disclosed Buys: 0 ($0)▼ Disclosed Sales: 0 ($0)

Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (CNTN)

No recent open-market Form 4 cluster sales or emergency dumps flagged on CNTN. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring CNTN)

✓Walkthrough of CNTN's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

CNTN // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -39.63%▼ DESCENDING CHANNEL

2026-10-30O $2.02H $2.05L $1.92C $1.95VOL 529.0K

RES: $2.46SUP: $1.55SMA50: $2.15SMA200: $2.97

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

CNTN Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 CNTN Butterfly Map → + Track CNTN →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on CNTN today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for CNTN. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for CNTN today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (CNTN)

Health Care Rank #613 of 1016 ⚔️ PDSB vs CNTN Full Matrix →

1. Head-to-Head Health Care Peer Comparison (CNTN vs. PDSB, PEPG, VRXA, CUE)

Industry: Biotechnology: Pharmaceutical Preparations (489 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Canton Strategic Holdings Inc. (CNTN) ranks #613 by composite RQD confidence (37/100, grade D-) and #601 by equity capitalization ($163.3M). Within this direct 5-issuer industry benchmark cohort, CNTN leads on earnings valuation at N/A trailing P/E, while CNTN leads on capital efficiency and profitability with -4.1% ROIC and — gross margin. VRXA currently holds the highest overall quantitative score in the immediate peer group at 60/100 (C-) compared with CNTN at 37/100 (D-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
CNTN ACTIVE Canton Strategic Holdings Inc.	D-	37/100	—	—	-4.1%	-4.88%	$163.3M	Benchmark Subject
PDSB PDS Biotechnology Corporation	D	45/100	—	—	-35.0%	-7.10%	$162.8M	/pdsb-vs-cntn →
PEPG PepGen Inc.	D-	38/100	—	—	-35.0%	-2.08%	$166.9M	/pepg-vs-cntn →
VRXA Veraxa Biotech AG	C-	60/100	—	—	—	+0.89%	$159.8M	/vrxa-vs-cntn →
CUE Cue Biopharma Inc.	E	33/100	—	—	-35.0%	-2.70%	$155.8M	/cue-vs-cntn →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001861657

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Canton Strategic Holdings Inc. (CNTN) reported GAAP revenue of $0 (N/A vs. FY2024 revenue of $0 ) , GAAP net income of -$35.9M, operating cash flow of -$16.1M, and free cash flow of -$16.1M (-47.9% YoY). On the balance sheet, CNTN closed FY2025 with $519.1M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 2/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$0	-$35.9M	-$16.1M	-$16.1M	$519.1M	—
FY2024 (FY)	2024-12-31	$0	-$12.2M	-$10.9M	-$10.9M	$3.7M	—
FY2023 (FY)	2023-12-31	$0	-$9.3M	-$7.3M	-$7.3M	—	—

3. CNTN Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is CNTN stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does CNTN compare to PDSB and PEPG in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for CNTN?

Where is CNTN trading relative to its 50-day, 200-day, and 52-week technical levels?

CNTN last traded at $1.95 (-4.88% on volume of 533,031 shares), positioning the stock -9.30% below its 50-day simple moving average ($2.15) and -34.34% below its 200-day simple moving average ($2.97). Across its 52-week range of $1.66 to $6.89, CNTN sits at the 5.5% percentile with a 14-day RSI of 46.9 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.71 to $2.19).

CNTN Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Are CNTN insiders and hedge funds buying or selling?

Roarable's SEC Form 4 and 13F Whale Thermometer currently classifies CNTN leadership and institutional positioning as: NET EXECUTIVE TRIMMING / PROFIT-TAKING.

Direct Sub-Reports: CNTN RQD Cockpit CNTN 12M Forecast CNTN Earnings & Move CNTN Dividends & DRIP CNTN Insiders & 13F CNTN Whale Options CNTN Profit Sankey CNTN News & Why

ROARABLE RATING BRIEF • RQD 37/100 (D-) ✓ STAGE-C NUMBER FIREWALL VERIFIED

CNTN — Canton Strategic Holdings Inc.: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5

As of: 2026-11-02T15:42:20Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, CNTN scores 37 out of 100, earning a D- grade and the verdict label "Roarable Sell — Vulnerable Balance Sheet & Flow." Across the five pillars: Fundamental Cash Engine scores 8/20 (ROIC of -4.1% and FCF yield of -9.87%), indicating the business is not currently generating returns on invested capital or free cash flow. Whale 13F Flow scores 8/20 for institutional accumulation and options positioning, a modest signal. Insider Conviction scores 3/20 on SEC Form 4 and Congressional PTR cluster flow, the weakest pillar and a signal of limited insider confidence. Macro Regime Fit scores 8/20 with a beta of 1.0, meaning market-level moves are expected to be mirrored one-for-one. Forensic Balance Sheet scores 10/20, reflecting an Altman Z of 2.5, a Piotroski F of 2/9, and a debt-to-equity ratio of 0.5.

For a prospective investor evaluating the stock today, the upside case rests on the tokenization news flow and any future reversal in cash generation, but the source data shows no current cash engine, weak insider flow, and a weak Piotroski reading. Valuation cannot be assessed on earnings because P/E and EV/EBITDA are not available in source data, and the negative free cash flow yield means traditional cash-based valuation support is absent.

Financial Trend

Period	Revenue	Operating Income	Net Income	EPS	FCF	Cash	Debt
FY 2025	$0.0M	$-20.1M	$-35.9M	N/A	$-16.1M	$12.0M	N/A
FY 2024	$0.0M	$-12.4M	$-12.2M	N/A	$-10.9M	$3.6M	N/A
FY 2023	$0.0M	$-9.5M	$-9.3M	N/A	$-7.3M	N/A	N/A

Per the SEC financials, the company reported no revenue and losses widened each year, with FY 2025 net income at $-35.9M against FY 2024 at $-12.2M. Gross, operating, and net margins are each 0% per the market data, and ROIC is -4.1%. The Altman Z-Score is 2.5 and the Piotroski F-Score is 2/9 per the Roarable RQD rating. Debt-to-equity is 0.5; cash rose from $3.6M at FY 2024 to $12.0M at FY 2025, but the source data does not provide a debt figure to assess the balance sheet further.

Recent Catalysts & News Wire Analysis

The news wire is dominated by a single theme: a tokenization initiative in which CNTN is described as moving to tokenize its own shares under a new SEC exemption and aiming for a first-trade debut on Canton. Headlines are tagged YELLOW (MARKET WIRE) except one GREEN CATALYST item, a CoinDesk report stating a tokenized stock venue on Canton could beat OKX–ICE to a first trade under the SEC framework. One item notes that more than 30 firms took part in a pilot covering digital stock transfers and Treasury deals. A BigGo Finance item references a Nov. 2 debut. Risk watch: the catalyst narrative is not paired with reported revenue in the source data. Proprietary signals: none, per the Butterfly Supply-Chain Graph.

Open Questions

What products or services generate the company's activity given that reported revenue is $0.0M in each period?
What debt obligations sit behind the Debt/Equity of 0.5, given that debt is N/A in every reported period?
What is the basis for the GREEN CATALYST tokenization claim, and what is its revenue or cash timeline?
What specific insider and 13F transactions underlie the 3/20 and 8/20 pillar scores?
What are the valuation metrics (EPS, P/E, EV/EBITDA) given that earnings figures are not reported?

CNTN Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Canton Strategic Holdings Inc. (CNTN) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to CNTN Debate Forum (3) ↓

🟡 MARKET WIRE unchainedcrypto.com • 6h ago

Canton Strategic Holdings Moves to Tokenize Its Own Shares Under the SEC's New Exemption

unchainedcrypto.com report covering Canton Strategic Holdings Inc. (CNTN) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE 24/7 Wall St. • 9h ago

The First Tokenized U.S. Stock Trades on Canton on Monday. What Would Have to Happen for CC to Double?

24/7 Wall St. report covering Canton Strategic Holdings Inc. (CNTN) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE TradingView • 12h ago

Canton Strategic Holdings Announces Intent to Become First Tokenized U.S. Equity

TradingView report covering Canton Strategic Holdings Inc. (CNTN) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Stock Titan • 15h ago

More than 30 firms took part in a pilot covering digital stock transfers and Treasury deals.

Stock Titan report covering Canton Strategic Holdings Inc. (CNTN) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE BigGo Finance • 18h ago

Canton-Linked Stock Trading Platform Aims to Be First, as CNTN Races for Nov. 2 Debut as First Tokenized U.S. Stock

BigGo Finance report covering Canton Strategic Holdings Inc. (CNTN) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST CoinDesk • 21h ago

Tokenized stock venue on Canton could beat OKX–ICE to first trade under SEC framework

CoinDesk report covering Canton Strategic Holdings Inc. (CNTN) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Kalkine Media • 1d ago

Canton Strategic Grants Jill E. Sommers 53,763 Stock Options at $1.86 Exercise Price

Kalkine Media report covering Canton Strategic Holdings Inc. (CNTN) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE https://www.siam.in/ • 1d ago

Canton Strategic Holdings (CNTN) Climbs 2.89% to $2.31, Holding Mid-Range - Fundamental Weighted

https://www.siam.in/ report covering Canton Strategic Holdings Inc. (CNTN) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

CNTN Bull vs. Bear Conversation Board — What's Your Call at $1.95?

🐂 33% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON CNTN 🐻 67% BEARISH CONVICTION

RO RoarDesk_Moderator Roarable Research Desk 🐻 BEARISH 🎯 Target: $1.72 (-11.8%)

📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is CNTN (D- • RQD 37/100) a Buy at $1.95?

Welcome to the CNTN (Canton Strategic Holdings Inc.) Roar Pit. Current RQD Composite is 37/100 (Roarable Sell — Vulnerable Balance Sheet & Flow) in Biotechnology: Pharmaceutical Preparations. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

BE BearTrap_Alert Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $1.58 (-19.0%)

Spot @ $1.95

Pump the brakes on CNTN — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on CNTN, but look at what you are paying: current EV/EBITDA multiples with tightening sector spreads. Unless Canton Strategic Holdings Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

DE DeltaGamma_99 Verified K Arena Trader 🐂 BULLISH 🎯 Target: $2.28 (+16.9%)

Spot @ $1.95

CNTN cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on CNTN, the market is fixating on short-term headline noise in Biotechnology: Pharmaceutical Preparations and ignoring the balance sheet and cash flow trajectory. At $1.95 (52-wk range $1.66 - $6.89), any beat on forward guidance forces shorts and underweight funds to chase.